ESR1 and breast cancer: Reasoning that expression of mitochondria-targeted estrogen receptors altered sensitivity to endocrine therapy agents and dynamic BH3 profiling response in breast cancer cells, we sought to identify the effect of mitochondrial estrogen receptors on mitochondrial bioenergetics.